Both in Pharmaceuticals
Lexaria Bioscience vs Lantern Pharma
Over the past year LEXX returned −75.6% and LTRN returned −83.8%; their daily moves had a correlation of 0.05.
LEXX −75.6% LTRN −83.8%Growth of $1, one year, split-adjusted
| Metric | LEXX | LTRN |
|---|---|---|
| Price | $4.07 | $0.5866 |
| Market cap | $8.6M | $8.8M |
| Today | +0.99% | −2.61% |
| 1 month | +25.6% | −38.5% |
| 6 months | −59.8% | −72.6% |
| Year to date | −56.0% | −80.6% |
| 1 year | −73.9% | −84.6% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 44.2× | — |
| Net cash | $3.6M | $7.4M |
| Dividend yield | — | — |
| Volatility (60d) | 195.3% | 91.8% |
| Short % of float | 16.0% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).